Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Roe

Showing results (241-250 of 468) with videos related to

Pageof 47
Sort By:
The American Journal of Cardiology|July 7, 2009
Predictors of early discontinuation of evidence-based medicine after acute coronary syndromeChiara Melloni, Karen P Alexander, Fang-Shu Ou, et al.
JAMA|December 10, 2009
Contraindicated medication use in dialysis patients undergoing percutaneous coronary interventionThomas T Tsai, Thomas M Maddox, Matthew T Roe, et al.
The American Journal of Cardiology|February 2, 2008
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarctionHenry H Ting, Matthew T Roe, Bernard J Gersh, et al.
Journal of the American Heart Association|April 13, 2017
Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary SyndromesSarah A Goldstein, L Kristin Newby, Derek D Cyr, et al.
American Heart Journal|September 2, 2008
Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE)Deepu Alexander, Fang-Shu Ou, Matthew T Roe, et al.
American Heart Journal|May 4, 2010
Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiativeShahyar Michael Gharacholou, Karen P Alexander, Anita Y Chen, et al.
The American Journal of Cardiology|March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ G Peterson, E J Topol, M T Roe, et al.
American Heart Journal|September 29, 2009
Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiativeErika R Gehrie, Harmony R Reynolds, Anita Y Chen, et al.
JACC. Cardiovascular Interventions|April 8, 2017
Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDRJacob A Doll, Dadi Dai, Matthew T Roe, et al.
American Heart Journal|October 18, 2003
Changing the model of care for patients with acute coronary syndromesMatthew T Roe, E Magnus Ohman, Charles V Pollack, et al.
Pageof 47

Showing results (241-250 of 468) with videos related to

Sort By:
Pageof 47
The American Journal of Cardiology|July 7, 2009
Predictors of early discontinuation of evidence-based medicine after acute coronary syndromeChiara Melloni, Karen P Alexander, Fang-Shu Ou, et al.
JAMA|December 10, 2009
Contraindicated medication use in dialysis patients undergoing percutaneous coronary interventionThomas T Tsai, Thomas M Maddox, Matthew T Roe, et al.
The American Journal of Cardiology|February 2, 2008
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarctionHenry H Ting, Matthew T Roe, Bernard J Gersh, et al.
Journal of the American Heart Association|April 13, 2017
Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary SyndromesSarah A Goldstein, L Kristin Newby, Derek D Cyr, et al.
American Heart Journal|September 2, 2008
Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE)Deepu Alexander, Fang-Shu Ou, Matthew T Roe, et al.
American Heart Journal|May 4, 2010
Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiativeShahyar Michael Gharacholou, Karen P Alexander, Anita Y Chen, et al.
The American Journal of Cardiology|March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ G Peterson, E J Topol, M T Roe, et al.
American Heart Journal|September 29, 2009
Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiativeErika R Gehrie, Harmony R Reynolds, Anita Y Chen, et al.
JACC. Cardiovascular Interventions|April 8, 2017
Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDRJacob A Doll, Dadi Dai, Matthew T Roe, et al.
American Heart Journal|October 18, 2003
Changing the model of care for patients with acute coronary syndromesMatthew T Roe, E Magnus Ohman, Charles V Pollack, et al.
Pageof 47